Facebook
Twitter
LinkedIn
ForwardTitle
Category
Credits
Event date
Cost
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Non-physician
$0.00
This activity was made possible in part by an educational grant from Novartis.
This is the third session in a four-part series, SHM Clinical Rapid Updates: Heart Failure. This session covers quality improvement focused approach for heart failure patient during hospitalization. Specific subtopics addressed in this session include:
1. Describe novel HF therapies that are potential QI targets including SGLT2 inhibitors alone and in combination w/ ANRI
2. Describe results of recent studies as potential QI targets including EMPRROR Reducediv and DAPA HFv
3. Discuss QI efforts in this area
This panel was moderated by Dr. Jagriti Chadha, MD, FHM. Our panelists included Dr. Tresa McNeal, MD, FACP, SFHM, Interim Chair for the Department of Medicine at BSW Medical Center in Temple, Texas, and Dr. Dustin Smith, MD, SFHM, Associate Professor of Medicine at Emory University School of Medicine in Atlanta, Georgia.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Non-physician
$0.00
This activity was made possible in part by an educational grant from Novartis.
In this fourth and final session in this series on heart failure, faculty will present opportunities, strategies and updates for heart failure care for hospitalists, including:
1. Hot off the press results including VICTORIAvii, GALACTICviii, AFFIRM-AHFix trials
2. Strategies to optimize inpatient care pathways including cardiology co-management
This session was moderated by Dr. Jagriti Chadha, MD, MPH, FACP, FHM. Panelists include Dr. Suchita Shah Sata, MD, FACP, SFHM, and Dr. Alfred Burger, MD, MS, FACP, SFHM.
$95.00
Surgical site infections (SSIs) are a major cause of postoperative illness, longer hospitalization, and increased healthcare costs, making the prevention and treatment of SSIs an important aspect of patient care for hospitalists. The following module outlines patient and procedural factors that increase the risk of SSIs, examines the basic principles of antimicrobial prophylaxis for SSI, reviews nonantibiotic interventions to lessen the risk of SSI, and outlines evaluation for and treatment of an SSI. In addition, a discussion of the controversy surrounding preoperative decolonization of Staphylococcus aureus is provided.
$95.00
Anticoagulant medications are commonly prescribed to patients in the United States for a number of medical problems. Interruptions in anticoagulation can result in severe adverse outcomes, including permanent disability and death, from arterial and venous thromboembolism. These medications, however, can also be associated with serious perioperative bleeding events. In fact, both bleeding and thromboembolic risks are amplified in the periprocedural period. This module addresses the risk of thromboembolism associated with periprocedural interruption of anticoagulation in patients with atrial fibrillation, a mechanical heart valve, or a history of venous thromboembolism.
$95.00
Patients with liver disease who undergo surgery, whether elective or emergent, are at increased risk for complications. In patients with cirrhosis, perioperative morbidity and mortality vary depending on the type of surgery. An accurate assessment of the presence and severity of acute or chronic liver disease is necessary to plan for perioperative management. Although most patients should continue liver-directed therapies, adjustments in medications may be necessary for certain liver diseases. This module outlines the risk associated with different types of surgery and identifies the elements of the preoperative evaluation for patients with cirrhosis. The influences on morbidity and mortality and formulation of pre- and postoperative care plans are reviewed as well.
$95.00
Pain is probably the most common presenting or associated symptom in patients in the hospital, and patients are often more concerned about being in pain than they are about the primary reason for admission. Pain is a completely subjective experience that is the consequence of the filtering, modulating, and distorting of the afferent nerve activity (i.e., nociceptive input) through the affective (i.e., limbic system) and cognitive processes unique to each individual. The following educational module discusses why postoperative pain requires treatment, outlines methods for performing a proper assessment of pain, provides strategies for utilizing patient-controlled analgesia safely and effectively, and summarizes the use of opioid and non-opioid analgesics in the postoperative setting to help hospitalists improve patients’ quality of recovery and life.
$95.00
Although general internists and subspecialists are familiar with prescribing and managing medications in typical outpatient and inpatient venues, the perioperative period represents a challenging and often unfamiliar setting. This module will outline the principles, available evidence, and expert opinion to be considered when making perioperative management recommendations for some of the most commonly prescribed medications.
$95.00
Perioperative cardiac complications are the most widely feared medical issues for the anesthesiologist, surgeon, and medical consultant as they approach a patient with the option of surgery. To assess for the preoperative cardiac risk, hospitalists should follow a step-wise algorithm. The following module reviews the risk assessment process and enables the hospitalist to order appropriate preoperative testing.
$95.00
Perioperative cardiac complications are the most widely feared medical issues for the anesthesiologist, surgeon, and medical consultant as they approach a patient in the perioperative period. Only recently have management strategies been addressed in high-quality studies. The following module explains the roles of medical and interventional treatments in lowering perioperative cardiac event rates. This module also discusses the typical presentation of coronary syndromes postoperatively and the management of antiplatelet and cardiac medications.
$95.00
Venous thromboembolism (VTE) prophylaxis in the surgical patient remains an important medical issue. Research has shown that VTE, which includes deep vein thrombosis and pulmonary embolism, occurs frequently in hospitalized patients who have undergone general, major gynecologic, major urologic, major orthopedic, or neurosurgery if preventive measures are not taken. Although it is impossible to predict with certainty which surgical patients will develop VTE, it is important for medical consultants to have a working knowledge of the different risk factors for VTE as well as current prophylaxis recommendations in order to employ appropriate strategies to reduce the risk of VTE. The following module discusses the clinical impact of VTE in surgical patients, reviews the various risk factors for VTE in surgical patients, and discusses prophylaxis options.